Dr. Martin Gleave, Urologist, Vancouver, BC [Video]

Dr Gleave is a Distinguished Professor and Chair of the Department of Urologic Sciences at UBC,and a British Columbia Leadership Chair. He is a clinician-scientist and urologic surgeon, and Co-Founder and Executive Director of the VPC, a UBC and National Centre of Excellence, publishing > 625 papers with >60,000 citations, an H-Index of 125, and attracting >$120M in research funding. He was appointed to the Order of Canada for his leadership role in developing new treatments for prostate cancer and for his research on mechanisms mediating treatment resistance in cancer. Dr. Gleave’s clinical practice focuses on urologic oncology in a multi-disciplinary environment spanning localized and advanced cancers. His research characterizes molecular mechanisms mediating treatment resistance in cancer, focusing on adaptive survival responses that drive acquired treatment resistance, and designing combination co-targeting strategies to create conditional lethality and improve cancer control. He patented several anti-cancer drugs and founded OncoGenex Pharmaceuticals to develop OGX-011 and …